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We previously reported a molecule, p64, which was tentatively named the ;, chain, copreeipitable with the fl chain of human interleukin-2 receptor 
(I L-2R). The present study demonstrated that the 7 chain, as ~,ell as the fl chain expressed on I L-2-responsivc cells, is phosphor'/lated on tyrosine 
residues in an IL-2-dependent manner in rive and in vitro. The in rive tyrosine phosphorylation f both chains was similarly induced within I 
mira after IL-2 stimulation, and their n vitro tyrosinc phosphorylation with the anti-lL-2Rp antibody-directed immunocomplex was also increased 
by treatment of cells with I L-2. These results uggest that a tyrosine kinase is associated with the/~)' subunit complex, of which activation by IL-2 
may result in transduction of intracellular signals. 
Interleukin-2 receptor; Tyrosine kinase 
1. INTRODUCTION 
Interleukin 2 (IL-2) is a well-characterized lyrnpho- 
kine that influences various types of cells, including T, 
B and NK cells, macrophages and glioma cells, through 
interaction with its specific receptor, IL-2 receptor (IL- 
2R), on their surfaces [1]. IL-2R is composed of at least 
two subunits, the ~ (p55) and/3 (p75) chains. IL-2Rfl but 
not IL-2Rot has been shown to be a molecule responsi- 
ble for transduction of growth signals when expressed 
on lymphoid and oligodendroglioma cells [2,3]. Recent 
studies using IL-2R~ and -/3 cDNA-transfected fibre- 
blast cell lines have shown thai the cz and ~ subunits are 
not enough to forna the high affinity functional IL-2 
receptor [4]. Therefore, we anticipated the presence of 
the other component involved in the IL-2R complex. 
We have recently identified a novel molecule, p64, des- 
ignated as the ?" chain of IL-2R0 associated with IL-2Rfl 
by immunoprecipitation of IL-2-treated cell lysates with 
an anti-lL-2R/3 monoelonal ntibody [5]. Transfection 
experiments with IL-2R]3 eDNA demonstrated that the 
association of IL-2R?' with I L-2R]3 correlates with the 
formation of functional IL-2R,6 [6]. 
IL-2 has been shown to induce tyrosine phosphoryla- 
tion of cellular proteins [7], and we and others have 
demonstrated that IL-2R]3 was phosphorylated at tyro- 
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sine residues in an IL-2-dependent manner [8-10]. In 
addition, recent reports showed that p56 '`k, a eytoplas. 
mic tyrosine kinase, is physically associated with IL- 
2R/3 [11] and activated by IL-2 stimulation [12]. We 
have, however, detected IL-2-induced tyrosine phos- 
phorylation of IL-2R~ in some p561~k-negative celllines 
(Kumaki et al., manuscript submitted for publication). 
Collectively itwas of interest to see whether the 2" chain 
is phosphorylated in response to IL-2 in rive and in 
vitro. In the present study we found that IL-2 induced 
tyrosine phosphorylation f IL-2Rz in vivo, and that a 
tyrosine kinase activated by IL-2 treatment was present 
in an anti-lL-2Rfl antibody-directed immunocomplex 
from cell lines that contained or lacked p56 ~k. 
2. MATERIALS AND METHODS 
2.1. Cells and monoclona! t~tibady 
MOLTS- 12 is a subline of MOLT.d, a human T-cell line, which was 
generated by stable transfection with IL-2R/~ eDNA and expresses 
exogenous IL-2R,g and endogenous IL-2R~, molecules, resulting in 
expression of 6,100 sites/cell of intermediate-affinity IL-2R (Kd = 1.7 
nM) [6]. M"I'.2 is an HTLV-i.tmnsformed human T-cell line. These 
cell lines were maintained in RPMI 1640 medium supplemented with 
10% FCS. TU 11 mAb {lgC 1) is specific for human IL.2Rp and does 
not inted'ere witl~ IL-2 binding to IL-2R,fl [13]. PY20 mAb (lgO 2b, 
ICN) is specific for phosphotyrosine [14]. 
2.2. Synthe.d:ed oligopeptides 
Two kinds ofoligopeptides, X.67 (RRVY FAYDPYGEE)and X-68 
(RRLPLNADAYLGL), were synthesized according to the published 
human IL-2Rp amino acid sequence [2]. X-67 consists of amino acids 
from position 354 to 364 and X-6B from 502 and 513 with ~ome 
modifications, namely that striae or threonine residues were ex- 
changed for glycinc or alanine, respectively, to remove the residues 
acting as accepter molecules of serine/threonine kinase reaction. One 
or two argininc residues were added at the N-terminal ends of these 
oligopeptides a shown with the R-R-SRC peptide [15]. 
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2.3. In vivo phosphor.elation and immunoprecipitation 
MOLT,a-12 ~lls (1 × 10 ~ cells) were labeled with [~P]ortho- 
phosphate (10 mei/ml, Amersham), treated with IL-2 and im- 
munopr~ipitated with TUI 1 mAb and Protein A-Sgpharose CL-4B 
(Pharmaeia) pretreated with rabbit anti-mouse IgG antibody 
(Zymed). as dcscribed previously [16], The Sepharos~ beads ",ver¢ 
washed and subjected to 2D PAGE. 
2,4. Phosphoamino acid .nalysis 
Gel pieces containing mol~ules ofinterest were excised from the 2D 
gels and subjected to phosphoamino acid analysis as demribed previ- 
ously [8]. Phosphoamino acids were quantitated with a Bio-lmage 
analyzer BA$2000 (Fuji Film)[17]. Phosphoamino acid markers ,~vere 
detected by ninhydrin staining. 
2.5. In vitro kittase assay 
MOLTFl-12 cells or MT-2 cells were starved of fetal bovine serum 
for 18 or 12 h, respectively. Cells (5 x 10 ~ cells/sample) were then 
stimulated with IL.2 for 10 rain at 37°C. Membrane Fraction of cells 
was prepared, lysed with the cell extraction buffer (50 mM TRIS-HCi, 
pH 7.5, 1% Nonidet P-40, 10 mM EDTA, 10 mM Na,P,O~, 2 mM 
NaaVO~, 2 mM phenylmethylsulfonyl fluoride an  1% aprotinin) and 
immunoprecipitated with TUII mAb. Immunoprecipitates w re re- 
suspended in 10/zl of kinase reaction buffer (50 mM HEPES, 10 raM 
MnCl:, 2 raM DTT, 0.3 mM Na~VO~, pH 7.3) with or without ex- 
ogenous ubstrates (X-67 or X-68). The kinase reaction was started 
by addition of 20 ,uCi of [;.,.UP]ATP (> 5,000 Ci/mmol, Amersham) 
and continued for 5 rain at 37°C. The reaction mixtur~ without ex- 
ogenous substrates was analyzed on 2D PAGE. 1D PAGE of 20% gel 
was used for the reaction mixture with exogenous substrates. 
3. RESULTS AND DISCUSSION 
We determined whether phosphorylation f IL-2R~, 
is induced by IL-2 in vivo. MOLTFl-12 cells, which have 
been shown to respond to IL-2 in growth signal and in 
tyrosine phosphorylation of IL-2R]/ under the FCS 
starved conditions (Kumaki et al., manuscript submit- 
ted for publication), were used for this analysis. Cells 
were labeled with [a:P]orthophosphate for 2 h and then 
treated with 30 nM IL-2 for the indicated times. Cell 
lysates were immunoprecipitated with TUI 1 mAb spe- 
cific for IL-2R~ and analyzed by 2D PAGE. Without 
IL-2 treatment (indicated as 0' in Fig. 1) TU11 mAb 
precipitated substantially a single molecule correspond- 
ing to theft chain (pI 4.3-4.7; mol. wt. 75 kDa), whereas 
I rain after IL-2 stimulation ot only the fl chain but 
also an additional molecule (pI 4.1-4.4; mol. wt. 64 
kDa), corresponding to the 7 chain, were precipitated 
(Fig. 1, left panels). The densities of both spots in- 
creased up to 15 rain after stimulation and then reached 
a plateau. 
Phosphorylated IL-2RFl and IL-2R7 mol~.cules were 
excised from the gel and analyzed for phosphoamino 
acids (Fig. 1, middle and right panels). The IL-2RFl 
molecule from the IL-2-untreated cells contained 
mainly phosphoserine and phosphothreonine, but little, 
if any, phosphotyrosine. After IL-2 treatment, in addi- 
tion to phosphoserine and phosphothreonine, 
phosphotyrosin¢ was dearly seen in phosphorylated IL-
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Fi 8, l, Kinetics of in vivo phospho~lation of IL-2RFl and -y. MOLTFl- 
12 ¢¢11s wer¢ labeled with [~:P]orthophosphate for 2 h and then stimu- 
lated with 30 aM IL-2 for the indicated times. Cell lysates were im- 
munoprecipitateA with TUI1 mAb and subjected to 2D PAGE (left 
panel). IL-2RFl and -y are indicated as arrowheads fl and 7, respec- 
tively. Spots corresponding to IL-2RFl and -7 were cxcis~ from the 
gel and analyzed for phosphoamino acids (middle or right panel), The 
position of phosphoserine (S). phosphothreonin¢ (T) and phosphoty- 
rosine (Y) ar~ indicated. 
2Rfl, as shown with the IL-2-dependent human T-cell 
line, ILT-Mat [8]. Similarly, phosphoserine and 
phosphothreonine of IL-2RFl increased as the incuba- 
tion period with IL-2 increased up to 30 min. The may 
imal level of tyrosine phosphorylation f IL-2R7 was 
seen 15 rain after stimulation, like IL-2RFl. Similar re- 
sults were obtained with PHA-stimulated normal 
human PBL (data not shown). 
it was still unclear, however, whether tyrosine phos- 
phorylation of IL-2R7 is induced by IL-2 stimulation, 
because IL-2R7 is detectable in the co-precipitate with 
IL-2RFl only after treatment of cells with IL-2. To ad- 
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Fig. 2. Kinetics of in vivo tyrosine phosphorylatio.'~ f cellular pro- 
teins. MOLTfl-12 coils were labeled and stimulated with IL-2 as de- 
scribed in the legend to Fig. 1. Cell lysatos were immunoprecipitated 
with PY20 mAb and subj~cted to 2D PAGE (left panel). Phosphoam- 
ino acid analy~es of IL-2R~ and -2' are shown in the middle and right 
panels, r~l~ctively. 
dress this question we attempted to detect IL-2R7 di- 
rectly with anti.phosphotyrosine a tibody, PY20 mAb. 
Immunoprecipitation with PY20 mAb of the [~2P]ortho- 
phosphate-labeled, IL-2 stimulated MOLTfl-12 cell ly- 
sate detected at least six tyrosine phosphorylated mole- 
cules. Among them two molecules were confirmed to be 
identical with IL-2Rfl and 7, as judged by identity of (i) 
molecular weights and isoelectric points and (iS) peptide 
mapping patterns~ and the fact that (iii) these two mol- 
ecules, which precipitated with PY20 mAb, were com- 
pletely pre-cleared with TU11 mAb (data not shown). 
The kinetics of the tyrosine phosphorylation f IL-2R7 
,C.Z  
Fig. 3. [n vitro phosphorylation of IL-2Rfl and -2' ia MOLTfl-12 cells. 
MOLT~-12 cells were stimulated with 30 nM IL-2 for l0 rain(B)or 
not (A). Ceil ysates were immuaoprccipitat~ with TUI l mAb and 
the immunoprecipitates w re subjected to immunocomplex kinas¢ 
assay and then analyzed by 2D PAGE. IL-2R~ and "2' are indicated 
as arrowheads fl and y. respectively, l L-2Rfl and -~, wer~ excised from 
the gel and analyzed for phosphoamino acids. C, D and E corr~poad 
to fl from IL.2.unstimulated c lls, fl and 7 from IL-2-stimulatcd ells. 
The position or phosphoserine (S). phosphothreonine (T) and 
phosphotyrosine (Y) are indicatecl. 
was examined by using PY20 mAb. 3UP-Labeled 
MOLTfl-12 cells were stimulated by 30 nM IL-2 for the 
indicated times, and then their lysates were precipitated 
with PY20 mAb. Before IL-2 stimulation only one spot, 
which is not identical with either IL-2R~ or 7, was 
detected (Fig. 2, arrowhead a). The IL-2Rfl and I spots 
became detectable I min after stimulation and increased 
up to 15 rain after stimulation (Fig. 2, left panels). The 
maximal evel of tyrosine phosphorylation of IL-2R7 
was seen within 15 min after stimulation, demonstrating 
that tyrosine phosphorylation of IL-2R7 was induced 
by IL-2 treatment, like IL-2Rfl (Fig. 2, middle and fight 
panels). This result was consistent with that obtained 
with TU l l  mAb. The IL-2-induced tyrosine phospho- 
rylation of the other four molecules was detectable 
within 5 rain after stimulation a d reached maximal 
levels at 15 min after stimulation, which appeared later 
than 1L-2Rfl and 7. These results indicated that the 
IL-2R7 chain, as well as the fl chain, is a substrate in 
tyrosine phosphorylation which is induced by IL-2 
treatment, and suggest that tyrosine and serine/threon- 
ine kinases are present in the IL-2/IL-2R complex con- 
taining IL-2Rfl and IL-2RT. 
The tyrosine or serine/threonine kinase activity ap- 
parently associated with the iL-2Rfl and T immune- 
complex was analyzed in vitro. Lysates of MOLT~-12 
cells treated or untreated with IL-2 were immunoprecip- 
Stated with TUI 1 mAb. Immunoprecipitates were sub- 
jected to a kinase reaction with [7-~2P]ATP and ana- 
lyzed by 2D PAGE. With the lysate from IL-2-un- 
treated MOLTfl-12 cells, IL-2Rfl but not IL-2R7 was 
detected as a phosphorylated protein (Fig. 3A). Treat- 
ment with IL-2 not only increased phosphoryiation of
IL-2Rfl but also made it possible to detect phosphoryl- 
arSon of IL-2R7 (Fig. 3B). These phosphorylated spots 
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fig. 4. In vitro phosphorylation ofIL-2wand -y in MT-2 c-ells, MT-2 
cells were used and analyzed as described in the legend to Fig. 3. 
of IL-2R/3 and y were excised from the gels and ana- 
lyzed for phosphoamino acids. Phosphotyrosine was 
seen dominantly in both IL-2Rp and IL-2Ry in the 
IL-2-treated cells, and phosphoserine and phosphothre- 
onine were rarely seen (Fig. 3C-E). These results raise 
the question of whether IL-2 induces activation of the 
tyrosinc kinase or an increase in the amount of the 
tyrosine kinase physically associated with IL-2R. At 
present we do not have enough data to answer this 
question. Very similar results were seen in an in vitro 
kinase experiment with the cell lysate from MT-2 cells 
expressing IL-2R/3 endogenously (Fig. 4). 
Besides tyrosine phosphorylation of IL-2R,8 and IL- 
2Ry, IL-2 also induced serine and threonine phospho- 
rylation of IL-2v in vivo. However, we previously 
reported that the kinetics of the serine and threonine 
phosphorylation appeared considerably slower than 
that of the tyrosine phosphorylation of IL-2Rb [S]. 
Taken together with results from our in vitro kinase 
assay a tyrosine kinase may be tightly associated with 
IL-2R, and its activation may be a primary effect of 
IL-2 stimulation followed by activation of serine/thre- 
onine kinase(s). Very recently, Fung et al. reported that 
IL-2Rj? immunocomplex has certain serine/threonine 
kinase activity in addition to tyrosinc kinase activity 
[IfA. 
IL-2-induced activation of tyrosine kinase in the IL- 
2Rjl immunocomplex was further examined with ex- 
ogenous ubstrates. The kinase reaction was carried out 
with the immunoprecipitates plus the exogenous oli- 
gopeptide substrates which were synthesized according 
to the human IL-2Rp amino acid sequence. With the 
TUl I mAb-directed immunocomplex from IL-2- 
treated MOLT,&12 and MT-2 cells significantly ele- 
vated tyrosine phosphorylation of the exogenous ub- 
strates was detected, whereas little if any phosphoryla- 
tion was seen with the immunocomplex from IL-Zun- 
treated cells (Fig. 5). cT-‘* , crncn togcthcr an association with 
IL-2R@ of a tyrosine kinase that is activated by interac- 
tion of IL-2 with the lL..2R complex seems likely, 
A tyrosine kinase molecule, p561ck, has been reported 
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Fig. 5. Immunocomplex kinase assay with the exogenous substrates. 
MOLTP-I2 cells (lane I-4) and MT-2 cells (lane 5-S) were stimulated 
with 30 nM IL-2 for 10 min (even lanes) ornot (odd lanes). Cell lysates 
were immunoprecipitated with TUI 1 mAb, and immunoprecipitates 
were subjcctcd to immunocomplex kinase assay with the X-67 sub- 
strate (lanes I, 2, 5 and 6) or X-G8 substrate (lanes 3.4, 7 and 8). The 
apparent position of phosphorylated X-67 and X-68 is indicated by 
arrowheads. 
to be activated by IL-2 stimulation [12] and to associate 
with IL-2Rp [1 11, suggesting the possibility that ~56”~ 
participates in the tyrosine pbosphorylation of IL-2Rp 
and IL-2Ry. We found, however, that MT-2 and MT-l 
cells, which are negative for ~56”~ [19], phosphorylate 
tyrosine residues of IL-2Rj and IL-2Ry in response to 
IL-2 in vivo (our unpublished data). Moreover, IL-% 
induced activation of the tyrosine kinase possibly asso- 
ciated with IL-2w was also demonstrated with the MT- 
2 cell lysates. These results indicate that a tyrosine ki- 
nase(s) other than ~56’~~ also participate(s) in phospho- 
rylation of IL-2R/? and IL-2Ry, at least in MT-2 cells. 
In the present study, we clearly demonstrate that IL-2 
induces tyrosine phosphorylation of the IL-2RjJ and y 
subunits through activation of the tyrosine kinase which 
is included in the IL-2 receptor complex. Similar tyro- 
sine kinase activities were reported in the immunocom- 
p!cx obtained by a.-t.----_ n i T1 TR,B or anti-IL-2 antibodies 
~lS,X]. Our preliminary study suggests that IL-2Ry 
itself is not a tyrosine kinase. Therefore, molecular and 
functional characterization of the tyrosine kinase which 
Volume 304, number 2,3 FEBS LETTERS June 1992 
is involved in IL-2- induced signal transduction is essen- 
tial for better understanding the mechanism of  signal 
transduction f rom IL-2R.  
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